ORTHOWORLD estimates Medtronic’s FY2Q18 revenue at US $739.0MM, -0.4% vs. FY2Q17 (quarter ended 10/27/17). The company posted YTD revenue of $2,226.0MM, +1.2% vs. the prior year’s period.
Medicrea received FDA 510(k) clearance to market IB3D™ 3D-printed interbody devices, and introduced its AdapTEK™ in-house additive manufacturing technology.
Highmark is reported to be the first and only private payor to issue exclusive positive coverage for Paradigm Spine’s coflex® Interlaminar Stabilization®.